Latest Posts

See what's new

FDA Approves Guardian™ Connect CGM System

I am excited to announce that the Food and Drug Administration (FDA) has approved our Guardian™ Connect continuous glucose monitoring (CGM) system for use in the United States. To hear more about this important milestone, watch my video message. The Guardian™ Connect system is the first smart standalone CGM system to help people with

Celebrate International Women’s Day — Meet Michele Blanshard

Michele Blanshard is a member of the Medtronic Australia Executive Leadership Team and an executive sponsor of the Medtronic Women’s Network — a high-priority initiative for Medtronic that aims to recruit and retain women in leadership positions and improve and achieve employee diversity. She also represents Medtronic as a board member for the Medical

Medtronic and Nutrino Address Impact of Nutrition in Type 2 Diabetes

As we continue to transform diabetes care to drive greater freedom and better health, we’ve placed a stronger focus on providing insights and solutions to doctors and patients to encourage better management of Type 2 diabetes. Our Pattern Snapshot provides healthcare professionals with a one-page report that helps them quickly interpret CGM data to

Inspired by Rebecca

Customers regularly reach out to me to give me feedback about our therapies. I recently received the testimonial below and it warmed my heart, so I thought I would share it with you. My name is Rebecca and I’ve had T1 for 32 years. I was diagnosed at the age of 4 and remember the

Inspired by Chip

I’d like to share a story about one of our employees, Chip Zimliki, senior regulatory affairs director. Chip has the unique experience of working at the FDA on insulin pump therapy and then joining our regulatory team to help get our ground-breaking technology approved in the U.S. Chip’s story highlights how his experience working

Inspired by Ana Maria

In November, in honor of Diabetes Awareness Month, we asked employees to share what inspires them to work at Medtronic Diabetes. I’d like to share one of those stories below. A few weeks ago, my family gathered to carry out a beloved family tradition. Each year, we put together Thanksgiving food baskets to benefit

Learning About Diabetes: Perspective on the Prevalence and Economic Burden of the Disease

WHAT IS DIABETES? There are three major types of diabetes: Type 1 diabetes, is an autoimmune disease, which is generally onset in children and young adults and is characterized by the loss of the pancreas’ ability to produce insulin. Type 2 diabetes is primarily found in adults who have resistance to the action of

Three Days in Puerto Rico

After driving through the streets with rubble, no traffic lights, downed trees and power lines, and being aware that electricity remains an elusive necessity throughout the island, I boarded my plane to leave Puerto Rico. Although I was there for only 3 days, I had an amazing opportunity to view our Juncos plant (which

Animas Customers: Medtronic is Here to Support You

Dear Animas Customers, Following the recent announcement that Animas will exit the market, we heard from many customers who are understandably anxious about what this means for them. Please know that we’re dedicated to supporting you through this transition and welcoming you to the Medtronic family. Our team is ready to support you and

Proving the Economic Benefits of Professional CGM

Our economic analysis of professional CGM using real-world data was published in the Journal of Medical Economics. With this analysis, Medtronic Diabetes is the first to demonstrate the significant clinical and health economic benefits of professional CGM products – such as iPro™2 – for people living with type 2 diabetes, and healthcare systems. Prior